Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

SCH-900105 is safe and advances from phase I to phase II trial

June 17, 2010

Idarubicin/busulphan improves outcome of autograft in patients with NPM1-mutant AML

June 17, 2010

GPR17 antagonist ticagrelor shows preclinical promise to treat demyelinating conditions

June 17, 2010

Endocyte presents interim phase I data on FR-targeting conjugates in solid tumors

June 17, 2010

Pridopidine beneficial in patients with Huntington's disease

June 17, 2010

Zolpidem improves limb dystonia

June 17, 2010

Promising data reported on house dust mite allergy therapies

June 17, 2010

Deferiprone reduces brain iron but does not lead to clinical improvement in PKAN

June 16, 2010

CF-102 shows anti-inflammatory and antitumor activity in vitro

June 16, 2010

Interim phase II data disclosed on PF-00299804 in recurrent/metastatic SCCHN

June 16, 2010

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...